Trial intelligence / Profile preview

Intracranial stenting in non-acute symptomatic ischemic stroke

NCT05063630Unknown

Sponsor
Can Tho Stroke International Services Hospital
Start
May 2019
Primary completion
Oct 2021
Countries
1
01

Overview

Randomised, open-label trial in ischemic stroke and Intracranial arterial stenosis (ICAS), sponsored by Can Tho Stroke International Services Hospital. Primary endpoint: Rate of recurrent ischemic stroke of the qualifying lesion in the territory of the symptomatic intracranial artery at 1 year. Status: unknown.

02

Conditions

ischemic strokeIntracranial arterial stenosis (ICAS)

Beyond the preview

Go deeper on NCT05063630.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05063630.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call